Dr. Juan Camilo Arjona Ferreira - 11 Aug 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of R&D & CMO
Signature
/s/ Faye C. Brown, as Attorney-in-Fact for Dr. Juan Camilo Arjona Ferreira
Issuer symbol
OGN
Transactions as of
11 Aug 2025
Net transactions value
-$38,005
Form type
4
Filing time
12 Aug 2025, 16:05:37 UTC
Previous filing
02 Apr 2025
Next filing
10 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Arjona Ferreira Juan Camilo Head of R&D & CMO C/O ORGANON &CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY /s/ Faye C. Brown, as Attorney-in-Fact for Dr. Juan Camilo Arjona Ferreira 12 Aug 2025 0001714080

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +11,519 +66% $0.000000 28,899 11 Aug 2025 Direct
transaction OGN Common Stock Tax liability $38,005 -4,122 -14% $9.22 24,777 11 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -11,519 -50% $0.000000 11,519 11 Aug 2025 Common Stock 11,519 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Organon common stock.
F2 These restricted stock units vest and are distributed as shares of Organon & Co. common stock in three equal installments with 11,519 shares having vested on August 11, 2025 and the third and final vesting to occur on August 11, 2026.

Remarks:

Exhibit 24 - Power of Attorney